Results 71 to 80 of about 1,133,949 (262)
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa +7 more
wiley +1 more source
Progression-free survival and survival estimates for TDM vs. NTDM.
, 2019 Progression-free survival (PFS, blue) and survival (orange) estimates. Estimates from TDM on solid lines; estimates from NTDM on dotted lines. Note: Progression-Free Survival: likelihood of staying in CP with either imatinib or second-generation TKI ...
Philip S. Bernard (8173509) +5 more
core +1 more source
Effects of physical activity on the development and progression of microvascular complications in type 1 diabetes : retrospective analysis of the DCCT study [PDF]
, 2013 Background: To examine the effects of physical activity on the development and progression of microvascular complications in patients with type 1 diabetes. Methods: A retrospective analysis of data from the Diabetes Control and Complications trial was
Krishnarajah Nirantharakumar +10 more
core +2 more sources
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Japan has one of the highest dialysis prevalence rates worldwide and a shrinking, aging population. Whether dialysis burden has entered a sustained post‐peak phase or whether recent declines partly reflect pandemic‐related disruptions remains uncertain.
Hatice Şahin +2 more
wiley +1 more source
Progression-free survival by the dose of the regorafenib
, 2016 Progression-free survival by the dose of the ...
Oriana Nanni (16186) +8 more
core +1 more source
FEBS Letters, EarlyView.Enteropathogenic E. coli (EPEC) infects the human intestinal epithelium, resulting in severe illness and diarrhoea. In this study, we compared the infection of cancer‐derived cell lines with human organoid‐derived models of the small intestine. We observed a delayed in attachment, inflammation and cell death on primary cells, indicating that host ...
Mastura Neyazi +5 more
wiley +1 more source
Progression-free survival curve of the 13 patients.
, 2018 The 5-year progression-free survival rate was 63.5%.
Yifei Wang (95207) +4 more
core +1 more source
Progression-free survival between the Collatamp group and the control group.
, 2022 There was no significant difference in the estimated 2-year progression-free survival rate between the two groups (log-rank p-value = 0.092).
Jaeim Lee (11204526) +3 more
core +1 more source
Organoids in pediatric cancer research
FEBS Letters, EarlyView.Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley +1 more source
WHAT NEXT? Supporting Student Progression from Furhther to Higher Education
, 2010 Examples from a visual resource for tutors supporting student progression from Further to Higher Education courses developed at the London College of Fashion.
Sarah Atkinson
core